Arbutus Biopharma Corp. (ABUS)
4.39
-0.07
(-1.57%)
USD |
NASDAQ |
Apr 08, 11:22
Arbutus Biopharma Cash from Investing (TTM) : 15.61M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Moderna, Inc. | 1.946B |
| Merck & Co., Inc. | -13.74B |
| Pfizer Inc. | -1.351B |
| ACADIA Pharmaceuticals, Inc. | -302.56M |
| Alnylam Pharmaceuticals, Inc. | 436.33M |